<--- Back to Details
First PageDocument Content
Chemical pathology / Oncology / Oncologists / EDRN / Texas Oncology / Medicine / Biomarkers / Biotechnology
Date: 2012-09-29 05:35:51
Chemical pathology
Oncology
Oncologists
EDRN
Texas Oncology
Medicine
Biomarkers
Biotechnology

NHMRC CLINICAL TRIALS CENTRE RESEARCH SEMINAR Methodological approaches in clinical trials of biomarkers for personalising treatment of advanced cancers Dr Chee Lee

Add to Reading List

Source URL: www.ctc.usyd.edu.au

Download Document from Source Website

File Size: 72,33 KB

Share Document on Facebook

Similar Documents

EDRN, Bethesda, MD, March 13-15, 2013  EMT-Like Circulating Tumor Cells (CTCs) in the Blood of Early-To-Late Stage Prostate Cancer Patients  Contact:

EDRN, Bethesda, MD, March 13-15, 2013 EMT-Like Circulating Tumor Cells (CTCs) in the Blood of Early-To-Late Stage Prostate Cancer Patients Contact:

DocID: 1lfau - View Document

EDRN	
  Data	
  Sharing	
  Policy	
   April	
  28,	
  2015	
  –	
  EDRN	
  Data	
  Sharing	
  and	
  Informatics	
  Subcommittee	
  	
   Purpose	
   The	
  release	
  and	
  sharing	
  of	
  reprod

EDRN  Data  Sharing  Policy   April  28,  2015  –  EDRN  Data  Sharing  and  Informatics  Subcommittee     Purpose   The  release  and  sharing  of  reprod

DocID: 1e9q4 - View Document

Public Health Sciences (PHS) is the home in the Biological Sciences Division to biostatistics, epidemiology and health services research. These core fields in public health research share a focus on the development and i

Public Health Sciences (PHS) is the home in the Biological Sciences Division to biostatistics, epidemiology and health services research. These core fields in public health research share a focus on the development and i

DocID: 19uUj - View Document

Blood Biomarkers for Triple Negative Breast Cancer Karen S. Anderson MD PhD Associate Professor Biodesign Institute, Arizona State University Mayo Clinic Arizona

Blood Biomarkers for Triple Negative Breast Cancer Karen S. Anderson MD PhD Associate Professor Biodesign Institute, Arizona State University Mayo Clinic Arizona

DocID: 18OsY - View Document

Biomarkers for Diagnosis and Prognostication of Lung Cancer and Mesothelioma

Biomarkers for Diagnosis and Prognostication of Lung Cancer and Mesothelioma

DocID: 18u8h - View Document